How long does it take to work?
Yonsa (abiraterone acetate) is a hormone therapy used to treat prostate cancer that has spread to other parts of the body and no longer responds to other medical and surgical treatments that lower testosterone - metastatic castration-resistant prostate cancer (CRPC). Yonsa is taken in combination with methylprednisolone.
Yonsa is a CYP17 inhibitor that works by blocking the production of androgens used to make testosterone. Androgens are a group of hormones that includes testosterone, which play a key role in the development and function of the prostate gland. Androgens are also involved in the initiation and progression of prostate cancer.
Yonsa contains the same active ingredient as Zytiga, but it provides the drug in a smaller, finer particle size (micronized) than Zytiga.
So, how quickly does Yonsa work?
Yonsa starts working quickly to lower testosterone levels in men with advanced prostate cancer.
The results of the STAAR study showed that 25% of the men with metastatic CRPC treated with Yonsa achieved averaged absolute testosterone levels at or below 0.1 ng/dl by days 9 and 10 of treatment.
In addition, more than 90 percent of the 24 men who received Yonsa during the study achieved absolute testosterone levels of ≤1 ng/dl during the 84 days that patients were monitored.
A decrease from baseline of ≥50 percent in prostate-specific antigen (PSA-50 response) levels was also observed in more than 65 percent of patients in the study on days 28, 56 and 84.
The STAAR study found Yonsa to be therapeutically equivalent to Zytiga based on serum testosterone levels.
Related medical questions
- Why is Yonsa taken with methylprednisolone?
- How long does it take to work?
- Is this a form of chemotherapy?
- Why is prednisone prescribed with Zytiga?
- What does abiraterone therapy do?
- Why is Yonsa taken with methylprednisolone?
- How long does it take to work?
- Is this a form of chemotherapy?
- Why is prednisone prescribed with Zytiga?
- What does abiraterone therapy do?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions